Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 1 hour 31 min ago

Walker & Dunlop Creative Team Earns Four 2024 Hermes Creative Awards

Mon, 08/19/2024 - 21:06
BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop, Inc. announced today that its creative team has been honored with multiple prestigious 2024 Hermes Creative Awards for their outstanding work on the Walker & Dunlop Website and the Walker Webcast. The newly designed Walker & Dunlop website received three Platinum Awards; the highest honor presented at this international competition. The team was recognized for its exceptional creativity across three electronic media categories includi

TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders

Mon, 08/19/2024 - 21:06
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) and KE Sdn. Bhd. is fair to Titan shareholders. Upon closing of the proposed transaction, Titan shareholders expect to own approximately 13.3% of the combined company. Halper Sadeh encourages Titan shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sade

HMN FINANCIAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HMN Financial, Inc. - HMNF

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of HMN Financial, Inc. (NasdaqGM: HMNF) to Alerus Financial Corporation (NasdaqCM: ALRS). Under the terms of the proposed transaction, shareholders of HMN will receive 1.25 shares of Alerus for each share of HMN that they own. KSF is seeking to determine whether this consideration and the process that led to it a

MARATHON OIL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marathon Oil Corporation - MRO

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marathon Oil Corporation (NYSE: MRO) to ConocoPhillips (NYSE: COP). Under the terms of the proposed transaction, shareholders of Marathon will receive 0.2550 shares of ConocoPhillips for each share of Marathon that they own. KSF is seeking to determine whether this consideration and the process that led to it

SILK ROAD MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silk Road Medical, Inc. - SILK

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silk Road Medical, Inc. (NasdaqGS: SILK) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Silk Road will receive $27.50 in cash for each share of Silk Road that they own. KSF is seeking to determine whether this consideration and the process that led to

AVANGRID INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avangrid, Inc. - AGR

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avangrid, Inc. (NYSE: AGR) to Iberdrola, S.A. Under the terms of the proposed transaction, shareholders of Avangrid will receive $35.75 in cash for each share of Avangrid that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the considerat

ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Alimera Sciences, Inc. (NasdaqGM: ALIM) to ANI Pharmaceuticals, Inc. (NasdaqGM: ANIP). Under the terms of the proposed transaction, shareholders of Alimera will receive $5.50 per share in cash at closing and one non-tradable contingent value right representing the right to receive up to $0.50 per share upon th

TERRAN ORBITAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terran Orbital Corporation - LLAP

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Terran Orbital Corporation (NYSE: LLAP) to Lockheed Martin Corporation (NYSE: LMT). Under the terms of the proposed transaction, shareholders of Terran Orbital will receive $0.25 in cash for each share of Terran Orbital that they own. KSF is seeking to determine whether this consideration and the process that

STELLANTIS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Stellantis N.V. - STLA

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 15, 2024 to file lead plaintiff applications in a securities class action lawsuit against Stellantis N.V. (NYSE: STLA), if they purchased the Company’s securities between February 15, 2024 to July 24, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the South

KELLANOVA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kellanova - K

Mon, 08/19/2024 - 21:06
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Kellanova (NYSE: K) to Mars, Incorporated. Under the terms of the proposed transaction, shareholders of Kellanova will receive $83.50 in cash for each share of Kellanova that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the considerati

Rosen Law Firm Encourages Customers Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation – CUBI

Mon, 08/19/2024 - 21:06
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Customers Bancorp, Inc. (NYSE: CUBI) resulting from allegations that Customers Bancorp may have issued materially misleading business information to the investing public. So What: If you purchased Customers Bancorp securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contin

IEP Investors Have Opportunity to Join Icahn Enterprises L.P. Securities Fraud Investigation with the Schall Law Firm

Mon, 08/19/2024 - 18:06
LOS ANGELES--(BUSINESS WIRE)--IEP Investors Have Opportunity to Join Icahn Enterprises L.P. Securities Fraud Investigation with the Schall Law Firm

Essex Property Trust Prices $200 Million Add-On Offering of its Senior Notes Due 2034 with a Reoffer Yield of 5.110%

Mon, 08/19/2024 - 18:06
SAN MATEO, Calif.--(BUSINESS WIRE)--Essex Property Trust, Inc. (NYSE: ESS) (“Essex”) announced today that its operating partnership, Essex Portfolio, L.P. (the “Issuer”), priced an underwritten public offering of $200 million in additional senior notes due 2034 with a reoffer yield of 5.110% (the “notes”). The notes will be issued as additional notes under the indenture pursuant to which the Issuer previously issued $350 million of 5.500% senior notes due 2034 (the “initial notes”). The notes w

Citizens Financial Group to Participate at the Barclays 22nd Annual Global Financial Services Conference

Mon, 08/19/2024 - 18:06
PROVIDENCE, R.I.--(BUSINESS WIRE)--Citizens Financial Group, Inc. (NYSE: CFG) announced today that Chairman and Chief Executive Officer Bruce Van Saun will participate at the Barclays 22nd Annual Global Financial Services Conference on Monday, September 9, 2024 at 9:45 am ET. The live webcast will be available at http://investor.citizensbank.com under Events & Presentations. About Citizens Financial Group, Inc. Citizens Financial Group, Inc. is one of the nation’s oldest and largest financi

Kirby McInerney LLP Reminds Vicor Corporation (VICR) Investors of Class Action Filing and Encourages Investors to Contact the Firm

Mon, 08/19/2024 - 18:06
NEW YORK--(BUSINESS WIRE)---- $VICR--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Vicor Corporation, Inc. (“Vicor” or the “Company”) (NASDAQ: VICR) securities during the period of April 26, 2023 and February 22, 2024, inclusive (“the Class Period”). Investors have until September 23, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit. [C

Newman Ferrara LLP Announces Corporate Governance Investigation of WM Technology, Inc. – MAPS

Mon, 08/19/2024 - 18:06
NEW YORK--(BUSINESS WIRE)---- $MAPS #NYTop100--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of WM Technology, Inc. (“WM Technology” or the “Company”) (NASDAQ:MAPS) into potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”). WM Technology, headquartered in Irvine, CA, is a technology and software infrastructure provider to the cannabis industry, comprised of the B2C platform Weedmaps, and B2B software WM Business. Newman F

Newman Ferrara LLP Announces Corporate Governance Investigation of TPG Inc. – TPG

Mon, 08/19/2024 - 18:06
NEW YORK--(BUSINESS WIRE)---- $TPG #NYTop100--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of TPG, Inc. (“TPG” or the “Company”) (NASDAQ:TPG) into potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”). TPG, headquartered in Fort Worth, TX, is an alternative asset firm, which invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, and Market Solutions. Newman Ferrara’s investigation focuse

Newman Ferrara LLP Announces Corporate Governance Investigation of Empire Petroleum Corporation – EP

Mon, 08/19/2024 - 18:06
NEW YORK--(BUSINESS WIRE)---- $EP #NYTop100--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Empire Petroleum Corporation (“Empire” or the “Company”) (NYSE:EP) into potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”). Empire, headquartered in Tulsa, OK, is a conventional oil and natural gas producer with a main focus in the US onshore. Newman Ferrara’s investigation focuses on decisions made by the Board, without shar

Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL

Mon, 08/19/2024 - 18:06
NEW YORK--(BUSINESS WIRE)---- $ZNTL #NYTop100--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Zentalis Pharmaceuticals, Inc. (“Zentalis” or the “Company”) (NASDAQ:ZNTL) into potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”). Zentalis, headquartered in San Diego, CA, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways

With $3.3 billion in deposits and 8 million customers, Mexico already stands out among Nu's operations

Mon, 08/19/2024 - 18:06
SÃO PAULO--(BUSINESS WIRE)--Standing as the number one business priority for Nu in 2024, Mexico has proven to be a savvy choice in the company's international expansion strategy: one year after the launch of Cuenta, the company has already surpassed 8 million customers in the country and $3.3 billion in deposits. These figures exceed those of Brazil at the same stage of operations: in the company’s home country, there were 7.7 million customers and less than $1 billion in deposits in Q1’19. Wit

Pages